Delaware Code Title 16 Sec. 2604 – Reimbursement by third-party payers
Current as of: 2023 | Check for updates
|
Other versions
Blood lead testing, screening, screening-related services, and diagnostic evaluations as required by § 2602 of this title are reimbursable under health insurance contracts and group and blanket health insurance under §§ 3337 and 3554 of Title 18, respectively.